Where Gilead Sciences Stands With Analysts
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 4 analysts have published their opinion on Gilead Sciences (NASDAQ:GILD) stock. The company has an average price target of $83.0, a decrease of 5.68% from the previous average price target of $88.00. The ratings include 2 bullish, 1 indifferent, and 1 somewhat bearish.
November 09, 2023 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Gilead Sciences has received mixed reviews from analysts, with an average price target of $83.0, down 5.68% from the previous target.
The mixed analyst ratings and the decrease in the average price target could lead to uncertainty among investors, potentially impacting the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100